Bungum IVF Lab Holding Aps

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  21.3% 21.3% 21.3% 2.3% 6.2%  
Credit score (0-100)  5 5 4 64 37  
Credit rating  B B B BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.4 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 -134 -84.3  
EBITDA  0.0 0.0 0.0 -151 -84.3  
EBIT  0.0 0.0 0.0 5,575 -5,366  
Pre-tax profit (PTP)  0.0 0.0 0.0 14,291.2 -4,915.2  
Net earnings  0.0 0.0 0.0 14,291.2 -4,960.7  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 14,291 -4,915  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  50.0 50.0 50.0 14,341 9,322  
Interest-bearing liabilities  0.0 0.0 0.0 63.3 42.4  
Balance sheet total (assets)  50.0 50.0 50.0 14,419 9,422  

Net Debt  -50.0 -50.0 -50.0 -8,630 -8,936  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 -134 -84.3  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 36.9%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  50 50 50 14,419 9,422  
Balance sheet change%  0.0% 0.0% 0.0% 28,739.0% -34.7%  
Added value  0.0 0.0 0.0 5,574.9 -5,366.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 1.0 -1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% -4,170.5% 6,362.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% 197.8% -40.7%  
ROI %  0.0% 0.0% 0.0% 198.0% -40.8%  
ROE %  0.0% 0.0% 0.0% 198.6% -41.9%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  100.0% 100.0% 100.0% 99.5% 98.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 5,717.1% 10,594.1%  
Gearing %  0.0% 0.0% 0.0% 0.4% 0.5%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 53.8% 126.9%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.0 111.0 89.3  
Current Ratio  0.0 0.0 0.0 111.0 89.3  
Cash and cash equivalent  50.0 50.0 50.0 8,693.7 8,978.3  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  50.0 50.0 50.0 8,615.3 66.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0